Drug development provider Icon PLC (Nasdaq: ICLR) saw its stock jump about 6% in value today after announcing second-quarter earnings that beat analysts’ expectations. The Dublin, Ireland–based company, which serves the pharmaceutical, biotechnology and medical device industries, also said it has acquired the Mapi Group, which provides patient-centered health outcomes research and commercialisation. Financial terms of […]
Starting a medtech company comes with a host of challenges, from regulation to financing to reimbursement. One way that companies can overcome those challenges, according to 2 industry experts, is to outsource some of the research and development work – and in the process, create a leaner, more flexible company.
Irish medical device outsourcer Creganna-Tactx Medical said today that it agreed to acquire Precision Wire Components LLC for an unspecified amount, saying it will re-brand as Creganna Medical.
Surgical devices maker Theragenics is looking to add some employees overseas at it prepares to ramp up manufacturing at a new facility in Costa Rica, part of larger outsourcing plans that included cuts in the U.S.
Updated 6/24/2014 at 5:20 p.m. EST with comments from CareFusion.
The first prefilled syringe was launched in early 1980’s. Since then, more and more pharmaceutical companies have chosen to provide their drug in this delivery form and the market has grown to an estimated value of $2.5 billion in 2010 according to a report from the consulting firm Visiongain.
One challenge facing prefilled syringe manufacturers is maintaining the sterility of the drug during transfer and transportation. Compromise in the syringe integrity could lead to microbiological contamination of the drug, which may result in serious medical consequences for patients. Subsequent product recalls could tarnish the public image of pharmaceutical companies and lead to negative financial consequences.